The Technology for Performance Improvement program (TPI) is a collaborative effort to develop pediatric product and technology solutions that have a measurable impact on clinical outcomes and patient care. The TPI working group is comprised of senior operations and clinical care professionals from the four leading pediatric hospitals in the IPI Pediatric Hospital Consortium: Lucile Packard Children’s Hospital at Stanford, Children’s Mercy Hospital in Kansas City, Rainbow Babies & Children’s Hospital in Cleveland, and Texas Children’s Hospital in Houston. New technologies will be tested and evaluated at participating hospitals to ensure that they are clinically and commercially feasible.


Our primary focus area is pediatric pressure ulcers, which result from hospital bedding as well as a wide array of medical devices used in pediatric and neonatal intensive care units. These include respiratory devices, tubes, EEG/EKG leads and wires, casts, braces, wraps and dressings. Many of these devices and the means for securing them to patients were designed for adults rather than babies and children, who are smaller and have more sensitive skin. The pressure ulcers that result from these devices can cause discomfort, infection, sepsis, and permanent skin damage.

The TPI collaborative defines the main problems and needs in the treatment and prevention of pressure ulcers. Combined with input from engineering partners and market experts, this in formation guides the development and evaluation of new medical devices and technologies to ameliorate the problem of pressure ulcers in children.


TPI and its partners also address other hospital-acquired conditions, which include medication errors, IV infiltrates, ventilator-associated pneumonia and surgical site infections. These conditions are especially detrimental to vulnerable pediatric patients and have been identified by pediatric hospitals nationwide as priority areas for performance improvement.